These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19001733)

  • 1. [Effect of mycophenolate mofetil on the expression of early inflammatory reaction in diabetic rats].
    Peng L; Zhang H; Xu G; Tang RH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):913-8. PubMed ID: 19001733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
    Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy.
    Wu Y; Dong J; Yuan L; Liang C; Ren K; Zhang W; Fang F; Shen J
    Cytokine; 2008 Oct; 44(1):85-91. PubMed ID: 18725182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z; Chen CX
    Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats.
    Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z
    Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
    Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes.
    Arellano-Buendía AS; Tostado-González M; García-Arroyo FE; Cristóbal-García M; Loredo-Mendoza ML; Tapia E; Sánchez-Lozada LG; Osorio-Alonso H
    Oxid Med Cell Longev; 2016; 2016():4693801. PubMed ID: 26955430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice.
    Seo JW; Kim YG; Lee SH; Lee A; Kim DJ; Jeong KH; Lee KH; Hwang SJ; Woo JS; Lim SJ; Kim W; Moon JY
    Biomed Res Int; 2015; 2015():301627. PubMed ID: 26345532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal injury induced in alloxan diabetic rats. Role of Mycophenolate Mofetil as therapeutic agent.
    Elseweidy MM; Elswefy SE; Ali AE; Shawky M
    Pathol Res Pract; 2014 Dec; 210(12):979-84. PubMed ID: 24939145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
    Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
    Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats.
    Wu X; Zha D; Xiang G; Zhang B; Xiao SY; Jia R
    Cytokine; 2006 Dec; 36(5-6):229-36. PubMed ID: 17337203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
    Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
    Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Volatile oil of Magnolia biondii inhibits expressions of P-selectin protein in serum and renal tissue of rats with diabetic nephropathy].
    Sun XP; Wang NS; Xue Q; Wang F
    Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):524-9. PubMed ID: 18471420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.
    Utimura R; Fujihara CK; Mattar AL; Malheiros DM; Noronha IL; Zatz R
    Kidney Int; 2003 Jan; 63(1):209-16. PubMed ID: 12472785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].
    Zhang LN; Xie XS; Zuo C; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):466-71. PubMed ID: 19627007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
    Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.